Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Gustavo J. Duarte"'
Autor:
Franklin Sosa, Mohammed Shaban, Jose Lopez, Gustavo J. Duarte, Swati Jain, Asma Khizar, Timothy Vittorio, Rishabh Mishra, Miguel Rodriguez Guerra
Publikováno v:
Clinical Medicine Insights: Cardiology, Vol 18 (2024)
The association between hyperuricemia and cardiovascular diseases has been studied for many years. Research has shown a link between high uric acid levels and increased risk of including coronary artery disease hypertension and other cardiovascular c
Externí odkaz:
https://doaj.org/article/c74156d40fd4490fb01e3b19408e9bf3
Autor:
Jose Lopez, Gustavo J. Duarte, Rosario A. Colombo, Andrea Folds, Fergie J. Losiniecki, Robert Chait
Publikováno v:
International Journal of Cardiology: Heart & Vasculature, Vol 43, Iss , Pp 101123- (2022)
Background: Left bundle branch block (LBBB) causes left ventricular dyssynchrony, and its presence with concomitant left ventricular dysfunction has been proven to play a synergistic role, worsening ventricular function. Our study seeks to further ex
Externí odkaz:
https://doaj.org/article/780abc3669b74d7c81a1f20598b859e2
Autor:
Amrin Kharawala, Jiyoung Seo, Diego Barzallo, Gabriel Hernandez Romero, Yunus Emre Demirhan, Gustavo J. Duarte, Charan Thej Reddy Vegivinti, Manuel Hache-Marliere, Prasanth Balasubramanian, Heitor Tavares Santos, Sanjana Nagraj, Majd Al Deen Alhuarrat, Dimitrios Karamanis, Dimitrios Varrias, Leonidas Palaiodimos
Publikováno v:
Journal of Clinical Medicine; Volume 12; Issue 11; Pages: 3629
Introduction: A significant increase in the use of computed tomography with pulmonary angiography (CTPA) for the diagnosis of pulmonary embolism (PE) has been observed in the past twenty years. We aimed to investigate whether the validated diagnostic
Autor:
José López, An Tran, Justin Mark, Gustavo J Duarte, Mohammed Shaban, Franklin Sosa, Rishabh Mishra, Swati Jain, Asma Khizar, Daniel Karpel, Giancarlo Acosta, Miguel Rodriguez-Guerra
Publikováno v:
Open Heart, Vol 10, Iss 2 (2023)
Introduction Clopidogrel is a P2Y12 inhibitor that has become a mainstay treatment following percutaneous intervention with drug-eluting stent placement to decrease restenosis and its potential complications, including sudden cardiac death and ischae
Externí odkaz:
https://doaj.org/article/8841cae4342142cea354fd8067ccb62c